August 2024 in “Research Square (Research Square)” Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.
Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.
Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.
Attractive women slightly worsened mood, green backgrounds improved mood, and older people had better moods.
Hair chemicals don't cause SLE but may increase skin issues in those with SLE.
New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.
Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.
March 2024 in “Research Square (Research Square)” Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.
Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.
February 2024 in “Hormones” Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.